|
|||||
![]() |
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter![]() |
Ticker | Owner | Relationship | Date | Transaction | Cost ![]() |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
MDT | Wall Brett A. | EVP & Pres Neuroscience | Jan 24 '25 | Option Exercise | 78.00 | 12,437 | 970,086 | 53,416 | Jan 27 05:35 PM |
MDT | Wall Brett A. | EVP & Pres Neuroscience | Jan 24 '25 | Sale | 90.00 | 12,437 | 1,119,330 | 40,979 | Jan 27 05:35 PM |
MDT | Wall Brett A. | Officer | Jan 24 '25 | Proposed Sale | 90.00 | 12,437 | 1,119,330 | Jan 24 02:34 PM | |
MDT | Wall Brett A. | EVP & Pres Neuroscience | Jan 08 '25 | Option Exercise | 74.84 | 6,850 | 512,654 | 50,558 | Jan 10 04:48 PM |
MDT | Wall Brett A. | EVP & Pres Neuroscience | Jan 08 '25 | Sale | 80.41 | 9,850 | 792,038 | 40,708 | Jan 10 04:48 PM |
MDT | Wall Brett A. | Officer | Jan 08 '25 | Proposed Sale | 80.41 | 9,850 | 792,038 | Jan 08 09:52 AM | |
MDT | Wall Brett A. | EVP & Pres Neuroscience | Aug 02 '24 | Option Exercise | 0.00 | 5,311 | 0 | 49,169 | Aug 06 06:16 PM |
MDT | Wall Brett A. | EVP & Pres Neuroscience | Dec 19 '23 | Sale | 82.17 | 4,997 | 410,603 | 28,910 | Dec 20 11:41 AM |
MDT | Wall Brett A. | EVP & Pres Neuroscience | Aug 14 '23 | Sale | 83.38 | 1,000 | 83,380 | 33,573 | Aug 16 05:16 PM |
MDT | Wall Brett A. | EVP & Pres Neuroscience | Jul 14 '23 | Sale | 87.97 | 2,000 | 175,940 | 23,948 | Jul 18 04:16 PM |
MDT | Wall Brett A. | EVP & Pres Neuroscience | Jun 18 '21 | Option Exercise | 74.84 | 1,168 | 87,413 | 22,655 | Jun 22 05:58 PM |
MDT | Wall Brett A. | EVP & Pres Neuroscience | Jun 21 '21 | Sale | 123.50 | 115 | 14,202 | 21,602 | Jun 22 05:58 PM |
MDT | Wall Brett A. | EVP & Pres Neuroscience | May 28 '21 | Option Exercise | 47.00 | 12,300 | 578,100 | 31,315 | Jun 02 06:00 PM |
MDT | Wall Brett A. | EVP & Pres Neuroscience | Jun 01 '21 | Sale | 128.07 | 2,473 | 316,717 | 21,487 | Jun 02 06:00 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite